• Facility design and project implementation
    • Conceptual design
    • Basis of Design (BOD)
    • Facility commissioning and qualification
  • Quality Management System implementation according to WHO, EU and USFDA standards
  • Protein- Polysaccharide Conjugation capability
  • Formulation Development
    • Viral Vaccines
    • Combination vaccines (recombinant protein-polysaccharide conjugate- toxoid-whole cell vaccines.
  • Polysaccharide Vaccine development
  • Development of toxoid based products
  • Development of Recombinant vaccines (yeast and bacterial host system)